Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $2.82
Liminatus Pharma, Inc. is a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is headquartered in LA Palma, California.
See the full interactive analysis & chart →Informational only — not investment advice.